Zdrowie i gospodarka · 22/07/2002

FDA Requests Public Comment on Proposed Collection of Information for Investigational New Drug Regulations

The Food and Drug Administration (FDA) is seeking public input on proposed regulations for clinical investigations of unapproved new drugs and biological products, as required by the Paperwork Reduction Act of 1995.